Our mission is to profoundly improve people’s lives by delivering a new class of RNA therapeutics – AOCs. Our proprietary AOCs are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to target the root cause of diseases previously untreatable with RNA therapeutics. Our advancing and expanding pipeline includes multiple skeletal muscle programs. We are also broadening the reach of AOCs beyond muscle tissues through both internal discovery efforts and key partnerships as the company continues to deliver on the RNA revolution.
Corporate Governance Documents
Corporate Governance involves the processes and procedures used to manage the business affairs of a company and includes the structure and balance of power between the management and board. This section provides bios of board and committee members, as well as charters and codes of conduct developed for the various committees.